department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

OXALIPLATIN · pharmadog

pharmadog
drugs
OXALIPLATIN

drug

patient view →

OXALIPLATIN

Marketedupdated 2mo ago

by Ingenus Pharmaceuticals LLC

Approved

community read0 votes

indications

investigational

Colorectal Cancer

all catalysts(4)

approval · 4

OXALIPLATIN — FDA approval

OXALIPLATIN — FDA approval

OXALIPLATIN — FDA approval

OXALIPLATIN — FDA approval

News(0)

no news has mentioned this drug yet

brand

OXALIPLATIN

generic

OXALIPLATIN

indication

Colon Cancer

phase

marketed

Data sources

openFDA · ClinicalTrials.gov

last refreshed just now

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 8

tagApproval16 co-mentions · 8 sources
drugXalox9 co-mentions · 9 sources
drugEntia9 co-mentions · 9 sources
tagOncology2 co-mentions · 1 sources
drugFAVLYXA1 co-mentions · 1 sources
drugFLUOROURACIL1 co-mentions · 1 sources
drugFOLFOX [leucovorin + fluorouracil + oxaliplatin]1 co-mentions · 1 sources
companyTehran University of Medical Sciences1 co-mentions · 1 sources

Trials studying OXALIPLATIN

phase2Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)recruitingn=298
phase2Phase Ib/IIa Open-label Study, to Evaluate Safety, Tolerability, and Antitumor Activity of HCB101 in Combination With Multiple Agents in Subjects With Advanced Gastric or Gastro-esophageal (GEJ) Adenocarcinomanot yet recruitingn=40
phase2A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignanciesactive not recruitingn=332
phase2Pan Tumor Rollover Studyrecruitingn=1,500
phase3A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphomarecruitingn=280
phase2A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancerrecruitingn=390
phase3A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinomarecruitingn=900
phase2A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the Treatment of Advanced Colorectal Cancernot yet recruitingn=71

more trials →